ACETAZOLAMIDE SODIUM

ACETAZOLAMIDE SODIUM was reported 6147 times

ACETAZOLAMIDE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VITREOUS INCARCERATION 6 0.8571
1 SOMATOSTATIN RECEPTOR SCAN ABNORMAL 6 0.5455
2 HYPOTONY MACULOPATHY 17 0.4146
3 HAIR FOLLICLE TUMOUR BENIGN 41 0.3694
4 CONGENITAL EMPHYSEMA 8 0.3077
5 EXERTIONAL RHABDOMYOLYSIS 11 0.2973
6 RETINOPATHY SICKLE CELL 5 0.2778
7 BRAIN STEM MICROHAEMORRHAGE 6 0.2143
8 FAT EMBOLISM SYNDROME 9 0.1636
9 CEREBELLAR MICROHAEMORRHAGE 6 0.1538
10 NUMB CHIN SYNDROME 6 0.1132
11 CONGENITAL INTESTINAL MALFORMATION 13 0.1121
12 CHOROIDAL DETACHMENT 61 0.1099
13 CONGENITAL CEREBRAL CYST 12 0.1071
14 CHOROIDAL EFFUSION 78 0.0971
15 BURKHOLDERIA TEST POSITIVE 11 0.0887
16 CAPILLARITIS 22 0.0797
17 TOTAL LUNG CAPACITY ABNORMAL 30 0.0771
18 RETINOPATHY HAEMORRHAGIC 5 0.0758
19 ACID-BASE BALANCE DISORDER MIXED 5 0.0667
20 ACUTE MYOPIA 12 0.0659
21 PULMONARY VASCULITIS 33 0.0613
22 SPIROMETRY ABNORMAL 32 0.0535
23 PALPABLE PURPURA 14 0.0511
24 MITE ALLERGY 33 0.0504
25 FLAT ANTERIOR CHAMBER OF EYE 9 0.0503
26 CONGENITAL HYPOTHYROIDISM 12 0.0465
27 OCULAR SURFACE DISEASE 13 0.0463
28 MACULAR DETACHMENT 11 0.0455
29 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 32 0.0437
30 CAVERNOUS SINUS THROMBOSIS 11 0.0433
31 DISSEMINATED BLASTOMYCOSIS 7 0.0409
32 HEPATOSPLENIC T-CELL LYMPHOMA 15 0.0404
33 IRIS NEOVASCULARISATION 5 0.0400
34 ANTERIOR CHAMBER DISORDER 9 0.0391
35 COMPLICATIONS OF BONE MARROW TRANSPLANT 14 0.0388
36 MYCOTIC ALLERGY 33 0.0386
37 HYPHAEMA 20 0.0383
38 DUST ALLERGY 33 0.0336
39 JOINT SPACE NARROWING 10 0.0336
40 NON-CARDIOGENIC PULMONARY OEDEMA 35 0.0331
41 ANGLE CLOSURE GLAUCOMA 84 0.0329
42 SINGLE UMBILICAL ARTERY 12 0.0325
43 CORNEAL DECOMPENSATION 5 0.0311
44 VOLVULUS OF SMALL BOWEL 6 0.0305
45 IDIOPATHIC INTRACRANIAL HYPERTENSION 66 0.0293
46 OPHTHALMIC VEIN THROMBOSIS 7 0.0289
47 ACIDOSIS HYPERCHLORAEMIC 17 0.0286
48 LARYNGEAL OBSTRUCTION 5 0.0273
49 SHORT STATURE 7 0.0267
50 OPEN ANGLE GLAUCOMA 16 0.0261
51 TUMOUR ULCERATION 6 0.0253
52 HYPOTONY OF EYE 10 0.0238
53 CONJUNCTIVITIS ALLERGIC 34 0.0229
54 CRYSTALLURIA 12 0.0221
55 NEURITIS 33 0.0214
56 BLOOD CORTICOTROPHIN INCREASED 6 0.0208
57 INTRAOCULAR PRESSURE DECREASED 10 0.0190
58 CSF PRESSURE INCREASED 5 0.0188
59 HYPERCALCIURIA 9 0.0183
60 SYMPTOM MASKED 13 0.0179
61 IRIS ADHESIONS 9 0.0175
62 FOETAL HEART RATE DECELERATION ABNORMALITY 12 0.0170
63 CORNEAL OEDEMA 38 0.0169
64 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 34 0.0167
65 DROPPED HEAD SYNDROME 6 0.0152
66 CENTRAL HYPOTHYROIDISM 5 0.0151
67 INTRACRANIAL PRESSURE INCREASED 84 0.0151
68 CATARACT SUBCAPSULAR 9 0.0148
69 PAPILLOEDEMA 66 0.0146
70 NEONATAL TACHYPNOEA 6 0.0145
71 RHINOCEREBRAL MUCORMYCOSIS 5 0.0144
72 CLEAR CELL RENAL CELL CARCINOMA 10 0.0144
73 BENIGN INTRACRANIAL HYPERTENSION 18 0.0143
74 OVERLAP SYNDROME 10 0.0143
75 TOXIC LEUKOENCEPHALOPATHY 10 0.0138
76 DRUG CLEARANCE DECREASED 18 0.0138
77 ALKALOSIS 5 0.0131
78 CEREBRAL VENOUS SINUS THROMBOSIS 11 0.0130
79 ACUTE CHEST SYNDROME 11 0.0125
80 INTELLECTUAL DISABILITY 19 0.0125
81 USE OF ACCESSORY RESPIRATORY MUSCLES 5 0.0121
82 CARDIAC ANEURYSM 12 0.0121
83 INTRAOCULAR PRESSURE INCREASED 152 0.0119
84 NORMOCHROMIC NORMOCYTIC ANAEMIA 35 0.0116
85 MYASTHENIC SYNDROME 9 0.0116
86 CIRCUMORAL OEDEMA 4 0.0115
87 OCULAR HYPERTENSION 22 0.0113
88 FORCED EXPIRATORY VOLUME DECREASED 32 0.0113
89 CERVICAL CORD COMPRESSION 4 0.0110
90 CEREBRAL MICROHAEMORRHAGE 5 0.0110
91 HYPERCAPNIA 33 0.0109
92 RESPIRATORY SYMPTOM 31 0.0109
93 METABOLIC ALKALOSIS 17 0.0106
94 SECONDARY ADRENOCORTICAL INSUFFICIENCY 16 0.0106
95 CYSTOID MACULAR OEDEMA 19 0.0101
96 GRUNTING 6 0.0100
97 CORTISOL INCREASED 6 0.0096
98 RETINAL VASCULAR OCCLUSION 7 0.0095
99 DEATH NEONATAL 13 0.0093
100 INTRACRANIAL VENOUS SINUS THROMBOSIS 10 0.0093
101 RESPIRATORY ALKALOSIS 15 0.0092
102 HYPOCHLORAEMIA 10 0.0085
103 MYOPIA 20 0.0084
104 INTRACRANIAL HYPOTENSION 5 0.0077
105 NEPHROCALCINOSIS 9 0.0076
106 CEREBROSPINAL FLUID LEAKAGE 14 0.0076
107 CROSS SENSITIVITY REACTION 7 0.0072
108 NEUROLOGICAL SYMPTOM 41 0.0072
109 SEROUS RETINAL DETACHMENT 6 0.0072
110 IRIDOCYCLITIS 22 0.0070
111 MESOTHELIOMA 9 0.0069
112 MACROCYTOSIS 8 0.0069
113 VITREOUS HAEMORRHAGE 19 0.0069
114 GRANULOMA ANNULARE 5 0.0068
115 CEREBELLAR ATROPHY 6 0.0068
116 CONJUNCTIVAL OEDEMA 7 0.0068
117 METABOLIC ACIDOSIS 215 0.0067
118 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 9 0.0067
119 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 11 0.0066
120 PUNCTATE KERATITIS 6 0.0065
121 ASPIRATION PLEURAL CAVITY 5 0.0065
122 MULTIPLE-DRUG RESISTANCE 20 0.0064
123 PULMONARY ALVEOLAR HAEMORRHAGE 35 0.0062
124 RETINOPATHY 23 0.0062
125 VITH NERVE PARALYSIS 7 0.0061
126 IDIOSYNCRATIC DRUG REACTION 6 0.0061
127 OCULAR VASCULAR DISORDER 5 0.0061
128 POSTPARTUM HAEMORRHAGE 8 0.0059
129 CORNEAL OPACITY 8 0.0059
130 MEDICATION OVERUSE HEADACHE 5 0.0058
131 RETINAL TOXICITY 6 0.0058
132 OPTIC NEUROPATHY 12 0.0057
133 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
134 INTRA-UTERINE DEATH 9 0.0056
135 SEBORRHOEIC KERATOSIS 8 0.0055
136 ACCOMMODATION DISORDER 4 0.0055
137 ARTERIOSCLEROSIS CORONARY ARTERY 36 0.0054
138 CORNEAL DEPOSITS 4 0.0054
139 HYPERSENSITIVITY VASCULITIS 14 0.0053
140 HYDROCEPHALUS 29 0.0053
141 HYPERAMMONAEMIC ENCEPHALOPATHY 9 0.0052
142 GLAUCOMA 99 0.0051
143 RESPIRATORY ACIDOSIS 20 0.0051
144 RENAL TUBULAR ACIDOSIS 11 0.0050
145 PERICARDIAL HAEMORRHAGE 11 0.0050
146 CORNEAL DISORDER 11 0.0050
147 OPTIC ATROPHY 8 0.0049
148 CONSCIOUSNESS FLUCTUATING 5 0.0048
149 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 5 0.0045
150 MENINGITIS ASEPTIC 20 0.0045
151 COLOUR BLINDNESS 4 0.0044
152 NEUROLOGICAL DECOMPENSATION 10 0.0043
153 ALLODYNIA 5 0.0043
154 AORTIC ARTERIOSCLEROSIS 11 0.0043
155 LABILE BLOOD PRESSURE 5 0.0042
156 PNEUMONIA INFLUENZAL 5 0.0042
157 CHRONIC RESPIRATORY FAILURE 5 0.0041
158 ANTISOCIAL BEHAVIOUR 4 0.0040
159 IMMUNE RECONSTITUTION SYNDROME 5 0.0039
160 AXILLARY MASS 4 0.0038
161 RETINAL DEGENERATION 5 0.0038
162 CUTANEOUS VASCULITIS 14 0.0038
163 ARTERIOSCLEROSIS 36 0.0038
164 HYPERAMMONAEMIA 19 0.0038
165 KERATOPATHY 6 0.0038
166 PUPILLARY REFLEX IMPAIRED 7 0.0038
167 SCLERITIS 6 0.0037
168 CARBON DIOXIDE INCREASED 5 0.0037
169 IRITIS 11 0.0036
170 MENINGITIS 24 0.0036
171 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
172 CARBON DIOXIDE DECREASED 4 0.0035
173 VISUAL FIELD DEFECT 25 0.0035
174 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
175 LYMPHOPROLIFERATIVE DISORDER 10 0.0034
176 ACIDOSIS 26 0.0034
177 ERYSIPELAS 17 0.0034
178 MYCOBACTERIUM AVIUM COMPLEX INFECTION 9 0.0033
179 FULL BLOOD COUNT ABNORMAL 35 0.0033
180 REBOUND ACID HYPERSECRETION 10 0.0033
181 EYE OEDEMA 8 0.0033
182 VITRITIS 6 0.0032
183 LEUKOENCEPHALOPATHY 12 0.0032
184 MYELOPATHY 6 0.0032
185 OBSTRUCTIVE AIRWAYS DISORDER 35 0.0031
186 CALCINOSIS 7 0.0031
187 ADJUSTMENT DISORDER 4 0.0031
188 HYPOVOLAEMIA 18 0.0031
189 RETINAL DETACHMENT 28 0.0030
190 DEAFNESS NEUROSENSORY 10 0.0030
191 NEPHROGENIC ANAEMIA 14 0.0030
192 VASCULITIS 35 0.0030
193 DYSLIPIDAEMIA 15 0.0030
194 AMMONIA INCREASED 15 0.0029
195 DIABETES INSIPIDUS 7 0.0029
196 BLOOD CHLORIDE INCREASED 5 0.0029
197 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
198 MACULOPATHY 10 0.0028
199 INTRAVENTRICULAR HAEMORRHAGE 7 0.0028
200 CONJUNCTIVAL HYPERAEMIA 10 0.0028
201 HYPOKALAEMIA 129 0.0028
202 HYPERPARATHYROIDISM SECONDARY 7 0.0028
203 RETINAL ARTERY OCCLUSION 7 0.0028
204 CEREBRAL ATROPHY 11 0.0028
205 CEREBRAL VENOUS THROMBOSIS 5 0.0028
206 BLEPHARITIS 11 0.0027
207 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
208 PRE-EXISTING CONDITION IMPROVED 17 0.0027
209 STILLBIRTH 13 0.0027
210 RETINAL DISORDER 7 0.0027
211 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
212 RENAL COLIC 6 0.0027
213 RED CELL DISTRIBUTION WIDTH INCREASED 11 0.0026
214 HYPOREFLEXIA 5 0.0026
215 SOCIAL AVOIDANT BEHAVIOUR 15 0.0026
216 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 141 0.0026
217 ELECTROENCEPHALOGRAM ABNORMAL 8 0.0025
218 RETINAL HAEMORRHAGE 18 0.0025
219 EYELID PAIN 5 0.0025
220 EUGLYCAEMIC DIABETIC KETOACIDOSIS 10 0.0024
221 OPTIC NEURITIS 22 0.0024
222 HYPERVENTILATION 14 0.0024
223 NODULE 31 0.0024
224 TORTICOLLIS 5 0.0024
225 ENDOPHTHALMITIS 14 0.0023
226 CARDIOPULMONARY FAILURE 9 0.0023
227 TOXIC EPIDERMAL NECROLYSIS 35 0.0023
228 ACUTE RESPIRATORY FAILURE 44 0.0023
229 TYPE I HYPERSENSITIVITY 8 0.0023
230 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
231 SICKLE CELL ANAEMIA WITH CRISIS 35 0.0022
232 INFUSION SITE PRURITUS 7 0.0022
233 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 57 0.0022
234 UVEITIS 30 0.0022
235 BRAIN OPERATION 5 0.0022
236 CUSHINGOID 7 0.0022
237 THERAPY PARTIAL RESPONDER 34 0.0022
238 PARADOXICAL DRUG REACTION 8 0.0022
239 ENDOTRACHEAL INTUBATION 6 0.0021
240 FOETAL GROWTH RESTRICTION 13 0.0021
241 BLOOD BICARBONATE DECREASED 4 0.0021
242 CARDIAC TAMPONADE 10 0.0021
243 VENTRICULAR SEPTAL DEFECT 12 0.0021
244 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16 0.0021
245 CYTOMEGALOVIRUS CHORIORETINITIS 4 0.0020
246 ATAXIA 24 0.0020
247 HYPOXIA 71 0.0020
248 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 34 0.0020
249 CATHETER SITE HAEMORRHAGE 5 0.0020
250 TOXIC ENCEPHALOPATHY 10 0.0020
251 KERATITIS 6 0.0020
252 HAEMORRHAGIC DIATHESIS 7 0.0020
253 MACULAR OEDEMA 11 0.0020
254 CANCER PAIN 5 0.0020
255 FEELING OF DESPAIR 9 0.0019
256 TACHYPNOEA 26 0.0019
257 THROMBOCYTOSIS 7 0.0019
258 PULMONARY FIBROSIS 35 0.0018
259 PURPURA 16 0.0018
260 ELECTROLYTE IMBALANCE 21 0.0018
261 VISUAL ACUITY REDUCED 60 0.0018
262 OLIGOHYDRAMNIOS 6 0.0018
263 CHOLESTATIC LIVER INJURY 4 0.0018
264 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
265 HYPOPHOSPHATAEMIA 13 0.0018
266 VITAMIN D DECREASED 15 0.0018
267 BLEPHAROSPASM 11 0.0017
268 PARALYSIS 25 0.0017
269 MUSCLE CONTRACTIONS INVOLUNTARY 6 0.0017
270 METABOLIC ENCEPHALOPATHY 5 0.0017
271 PRODUCT ADMINISTRATION INTERRUPTED 13 0.0017
272 LUNG DISORDER 81 0.0017
273 PHOTOPHOBIA 31 0.0016
274 THERAPY NON-RESPONDER 74 0.0016
275 CARDIAC FAILURE CHRONIC 7 0.0016
276 FACIAL PARALYSIS 14 0.0016
277 HORMONE LEVEL ABNORMAL 8 0.0016
278 INTRACARDIAC THROMBUS 5 0.0016
279 FLANK PAIN 15 0.0016
280 RESPIRATORY RATE DECREASED 5 0.0016
281 END STAGE RENAL DISEASE 29 0.0016
282 INFUSION SITE SWELLING 10 0.0016
283 ENCEPHALOPATHY 39 0.0016
284 COMMUNICATION DISORDER 6 0.0016
285 DRUG RESISTANCE 40 0.0016
286 FOETAL DEATH 8 0.0015
287 HAEMOPTYSIS 43 0.0015
288 EYE OPERATION 7 0.0015
289 ARTHRITIS INFECTIVE 7 0.0015
290 EXPOSURE VIA BREAST MILK 6 0.0015
291 ABORTION INDUCED 14 0.0015
292 EYE PAIN 82 0.0015
293 INTESTINAL ISCHAEMIA 8 0.0015
294 ENCEPHALITIS 10 0.0014
295 HYPOTHYROIDISM 46 0.0014
296 ATRIAL SEPTAL DEFECT 12 0.0014
297 INFUSION SITE ERYTHEMA 12 0.0014
298 BREATH SOUNDS ABNORMAL 7 0.0014
299 RESPIRATORY DISTRESS 39 0.0014
300 CEREBRAL THROMBOSIS 4 0.0014
301 GRAND MAL CONVULSION 13 0.0014
302 PYODERMA GANGRENOSUM 5 0.0014
303 EYE INFLAMMATION 13 0.0014
304 PERIPHERAL VASCULAR DISORDER 7 0.0014
305 POLYURIA 11 0.0013
306 THROMBOTIC MICROANGIOPATHY 13 0.0013
307 STATUS EPILEPTICUS 15 0.0013
308 NYSTAGMUS 7 0.0013
309 OSTEOPENIA 20 0.0013
310 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
311 BLINDNESS 53 0.0013
312 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
313 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
314 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
315 PHARYNGITIS 16 0.0013
316 APHTHOUS ULCER 10 0.0013
317 DIPLOPIA 33 0.0013
318 BLOOD ALBUMIN DECREASED 10 0.0013
319 FOREIGN BODY SENSATION IN EYES 8 0.0013
320 TENDERNESS 13 0.0012
321 EPILEPSY 38 0.0012
322 HYPERVOLAEMIA 6 0.0012
323 HEREDITARY ANGIOEDEMA 13 0.0012
324 BLINDNESS UNILATERAL 17 0.0012
325 SPLENOMEGALY 14 0.0012
326 BRAIN OEDEMA 15 0.0012
327 COLITIS ISCHAEMIC 8 0.0012
328 CATARACT OPERATION 7 0.0012
329 SUBARACHNOID HAEMORRHAGE 12 0.0012
330 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
331 PETIT MAL EPILEPSY 6 0.0012
332 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
333 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
334 STEVENS-JOHNSON SYNDROME 26 0.0012
335 ANURIA 10 0.0012
336 POOR VENOUS ACCESS 12 0.0012
337 OCULAR DISCOMFORT 13 0.0012
338 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
339 DEFAECATION URGENCY 8 0.0011
340 RIGHT VENTRICULAR FAILURE 8 0.0011
341 RESPIRATORY FAILURE 83 0.0011
342 EYE DISORDER 37 0.0011
343 DELIRIUM 38 0.0011
344 SKIN ABRASION 5 0.0011
345 APPETITE DISORDER 7 0.0011
346 HYPERKALAEMIA 37 0.0011
347 PSYCHOTIC DISORDER 31 0.0010
348 SLEEP APNOEA SYNDROME 20 0.0010
349 HYPOVOLAEMIC SHOCK 5 0.0010
350 MATERNAL DRUGS AFFECTING FOETUS 8 0.0010
351 HAEMOLYSIS 8 0.0010
352 ATELECTASIS 10 0.0010
353 FOETAL EXPOSURE DURING PREGNANCY 84 0.0010
354 GASTROENTERITIS 15 0.0010
355 VITAMIN D DEFICIENCY 10 0.0010
356 URINE ODOUR ABNORMAL 6 0.0010
357 CONDITION AGGRAVATED 308 0.0010
358 ATRIAL FLUTTER 8 0.0010
359 HYPOTONIA 10 0.0010
360 AZOTAEMIA 4 0.0010
361 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 52 0.0010
362 CYSTITIS HAEMORRHAGIC 4 0.0010
363 CATARACT 59 0.0010
364 DYSPHORIA 5 0.0010
365 HEPATOCELLULAR INJURY 14 0.0010
366 PRODUCTIVE COUGH 47 0.0010
367 EYE HAEMORRHAGE 13 0.0010
368 ACUTE KIDNEY INJURY 149 0.0010
369 REBOUND EFFECT 11 0.0010
370 INFUSION SITE EXTRAVASATION 6 0.0010
371 PNEUMONIA ASPIRATION 24 0.0010
372 PARTIAL SEIZURES 5 0.0010
373 VISUAL IMPAIRMENT 118 0.0010
374 LACTIC ACIDOSIS 30 0.0009
375 COGNITIVE DISORDER 43 0.0009
376 CONJUNCTIVITIS 17 0.0009
377 INSURANCE ISSUE 14 0.0009
378 FAECALOMA 5 0.0009
379 RENAL INJURY 27 0.0009
380 AUTISM SPECTRUM DISORDER 5 0.0009
381 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
382 HYPOKINESIA 13 0.0009
383 POST-TRAUMATIC STRESS DISORDER 6 0.0009
384 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 43 0.0009
385 AFFECTIVE DISORDER 7 0.0009
386 PNEUMOTHORAX 14 0.0009
387 SLUGGISHNESS 9 0.0009
388 LOW BIRTH WEIGHT BABY 7 0.0009
389 IMPAIRED GASTRIC EMPTYING 12 0.0009
390 IMPAIRED DRIVING ABILITY 10 0.0009
391 NEPHROLITHIASIS 40 0.0009
392 PNEUMONIA BACTERIAL 8 0.0009
393 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 62 0.0009
394 CHRONIC KIDNEY DISEASE 66 0.0009
395 LYMPHOEDEMA 6 0.0009
396 MYASTHENIA GRAVIS 7 0.0009
397 EYE DISCHARGE 9 0.0009
398 PERSONALITY CHANGE 8 0.0009
399 INFUSION SITE PAIN 11 0.0009
400 HYPERAESTHESIA 7 0.0009
401 PRODUCT USE IN UNAPPROVED INDICATION 211 0.0009
402 OFF LABEL USE 741 0.0008
403 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
404 HEART RATE IRREGULAR 19 0.0008
405 DRUG INTERACTION 133 0.0008
406 LIVE BIRTH 7 0.0008
407 WHEEZING 49 0.0008
408 TOOTH FRACTURE 9 0.0008
409 BLINDNESS TRANSIENT 6 0.0008
410 PSYCHIATRIC SYMPTOM 6 0.0008
411 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
412 VISION BLURRED 111 0.0008
413 SCOLIOSIS 5 0.0008
414 SEIZURE 92 0.0008
415 HYPERGLYCAEMIA 29 0.0008
416 PEMPHIGOID 6 0.0008
417 IMMUNOSUPPRESSION 7 0.0008
418 SCREAMING 5 0.0008
419 TREATMENT FAILURE 65 0.0008
420 MYDRIASIS 10 0.0008
421 CONCUSSION 6 0.0008
422 LEUKOCYTOSIS 14 0.0008
423 BRADYCARDIA 41 0.0008
424 PULMONARY HAEMORRHAGE 6 0.0008
425 DRUG INTOLERANCE 74 0.0008
426 TORSADE DE POINTES 6 0.0008
427 PARAESTHESIA 120 0.0008
428 RENAL IMPAIRMENT 64 0.0008
429 ORAL PAIN 17 0.0008
430 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
431 BACTERAEMIA 9 0.0008
432 TRICUSPID VALVE INCOMPETENCE 6 0.0008
433 BLOOD PRESSURE FLUCTUATION 18 0.0007
434 NEUROTOXICITY 13 0.0007
435 BEHAVIOUR DISORDER 4 0.0007
436 BIPOLAR DISORDER 8 0.0007
437 PRODUCT PRESCRIBING ISSUE 16 0.0007
438 CARDIOMEGALY 9 0.0007
439 EYE MOVEMENT DISORDER 5 0.0007
440 SOMNOLENCE 147 0.0007
441 DROOLING 5 0.0007
442 MENTAL STATUS CHANGES 20 0.0007
443 RENAL TUBULAR NECROSIS 7 0.0007
444 SKIN INFECTION 8 0.0007
445 ACUTE PULMONARY OEDEMA 4 0.0007
446 ACUTE MYOCARDIAL INFARCTION 21 0.0007
447 MUSCLE ATROPHY 9 0.0007
448 DELUSION 11 0.0007
449 MIGRAINE 67 0.0007
450 BRAIN FOG 11 0.0007
451 PRESCRIBED UNDERDOSE 14 0.0007
452 DRUG-INDUCED LIVER INJURY 22 0.0007
453 BLOOD POTASSIUM DECREASED 21 0.0007
454 CYTOKINE RELEASE SYNDROME 14 0.0007
455 TREATMENT NONCOMPLIANCE 38 0.0007
456 MUSCLE TWITCHING 16 0.0007
457 PANIC REACTION 5 0.0007
458 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
459 PULMONARY OEDEMA 31 0.0007
460 PERICARDIAL EFFUSION 16 0.0007
461 PLEURAL EFFUSION 42 0.0007
462 BRADYKINESIA 4 0.0007
463 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
464 TINNITUS 31 0.0007
465 OCULAR HYPERAEMIA 32 0.0007
466 EAR PAIN 13 0.0007
467 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
468 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
469 IRRITABILITY 40 0.0007
470 DRUG LEVEL INCREASED 11 0.0007
471 PAROSMIA 5 0.0007
472 LETHARGY 38 0.0007
473 ADRENAL INSUFFICIENCY 8 0.0007
474 OXYGEN SATURATION DECREASED 37 0.0007
475 HAEMODYNAMIC INSTABILITY 5 0.0007
476 RENAL FAILURE 87 0.0007
477 BRAIN NEOPLASM 6 0.0007
478 RESPIRATORY TRACT INFECTION 17 0.0007
479 INCREASED TENDENCY TO BRUISE 6 0.0007
480 DISEASE RECURRENCE 31 0.0007
481 IRON DEFICIENCY ANAEMIA 6 0.0006
482 DRUG EXPOSURE DURING PREGNANCY 22 0.0006
483 THROMBOSIS 52 0.0006
484 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
485 EXPOSURE DURING PREGNANCY 40 0.0006
486 HEPATIC ENCEPHALOPATHY 6 0.0006
487 APNOEA 5 0.0006
488 TOXICITY TO VARIOUS AGENTS 108 0.0006
489 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
490 SEASONAL ALLERGY 9 0.0006
491 RASH MACULO-PAPULAR 14 0.0006
492 PULMONARY HYPERTENSION 13 0.0006
493 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
494 CARDIO-RESPIRATORY ARREST 26 0.0006
495 AGGRESSION 31 0.0006
496 LIVER FUNCTION TEST ABNORMAL 18 0.0006
497 FRUSTRATION TOLERANCE DECREASED 5 0.0006
498 MITRAL VALVE INCOMPETENCE 7 0.0006
499 MOUTH ULCERATION 13 0.0006
500 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
501 RENAL FAILURE ACUTE 26 0.0006
502 CONFUSIONAL STATE 99 0.0006
503 BRADYPHRENIA 4 0.0006
504 BODY TEMPERATURE DECREASED 6 0.0006
505 SHOCK 14 0.0006
506 BEDRIDDEN 8 0.0006
507 DISORIENTATION 24 0.0006
508 HYPONATRAEMIA 34 0.0006
509 FACE OEDEMA 10 0.0006
510 COVID-19 PNEUMONIA 7 0.0006
511 DYSKINESIA 24 0.0006
512 TRANSAMINASES INCREASED 13 0.0006
513 DYSPNOEA EXERTIONAL 22 0.0006
514 DIABETIC KETOACIDOSIS 14 0.0006
515 INFLAMMATION 30 0.0006
516 DRY EYE 29 0.0006
517 POST PROCEDURAL COMPLICATION 11 0.0006
518 URINE OUTPUT DECREASED 5 0.0006
519 DEHYDRATION 76 0.0006
520 SCRATCH 6 0.0006
521 HYPOTENSION 114 0.0006
522 PANCREATITIS 30 0.0006
523 SLEEP DISORDER 40 0.0006
524 LYMPHOPENIA 8 0.0006
525 HEAD DISCOMFORT 10 0.0006
526 TYPE 2 DIABETES MELLITUS 19 0.0006
527 CYST 7 0.0006
528 SYSTEMIC LUPUS ERYTHEMATOSUS 20 0.0006
529 LIVER FUNCTION TEST INCREASED 12 0.0006
530 DISEASE PROGRESSION 66 0.0006
531 CARDIOGENIC SHOCK 8 0.0006
532 HAEMATOCRIT DECREASED 11 0.0006
533 OEDEMA 30 0.0006
534 PREGNANCY 11 0.0005
535 CARDIAC FAILURE CONGESTIVE 44 0.0005
536 BLOOD GLUCOSE FLUCTUATION 6 0.0005
537 BALANCE DISORDER 47 0.0005
538 ANOREXIA 7 0.0005
539 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
540 TASTE DISORDER 11 0.0005
541 UPPER RESPIRATORY TRACT INFECTION 25 0.0005
542 CEREBRAL DISORDER 4 0.0005
543 COAGULOPATHY 9 0.0005
544 BLOOD UREA INCREASED 9 0.0005
545 NECK PAIN 30 0.0005
546 SINUSITIS 55 0.0005
547 DRUG INEFFECTIVE 706 0.0005
548 CANDIDA INFECTION 9 0.0005
549 GASTRITIS 14 0.0005
550 CHROMATURIA 12 0.0005
551 EYE INFECTION 6 0.0005
552 DYSARTHRIA 20 0.0005
553 PULMONARY CONGESTION 7 0.0005
554 LACRIMATION INCREASED 16 0.0005
555 SEPTIC SHOCK 23 0.0005
556 ECONOMIC PROBLEM 8 0.0005
557 EAR INFECTION 14 0.0005
558 MICTURITION URGENCY 6 0.0005
559 HALLUCINATION, VISUAL 11 0.0005
560 PULMONARY EMBOLISM 49 0.0005
561 SPINAL PAIN 6 0.0005
562 PERIPHERAL COLDNESS 7 0.0005
563 HEPATIC FUNCTION ABNORMAL 19 0.0005
564 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
565 CYANOSIS 8 0.0005
566 VITREOUS FLOATERS 5 0.0005
567 HYPOPHAGIA 13 0.0005
568 ASTHMA 57 0.0005
569 MYOCLONUS 6 0.0005
570 URINARY TRACT INFECTION 85 0.0005
571 SEDATION 13 0.0005
572 RESTLESS LEGS SYNDROME 9 0.0005
573 THERAPEUTIC RESPONSE DECREASED 30 0.0005
574 HYPOTHERMIA 5 0.0005
575 MUSCLE TIGHTNESS 8 0.0005
576 NASAL CONGESTION 29 0.0005
577 EYELID PTOSIS 5 0.0005
578 CEREBRAL INFARCTION 12 0.0005
579 RESPIRATORY DEPRESSION 6 0.0005
580 AGRANULOCYTOSIS 9 0.0005
581 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
582 COMA 23 0.0005
583 FLUID OVERLOAD 7 0.0005
584 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
585 CARDIAC ARREST 39 0.0005
586 CYSTITIS 15 0.0005
587 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
588 HEADACHE 294 0.0005
589 UNRESPONSIVE TO STIMULI 12 0.0005
590 DECREASED ACTIVITY 5 0.0005
591 AMNESIA 30 0.0005
592 BACK INJURY 5 0.0005
593 DYSPNOEA 259 0.0005
594 ASPIRATION 5 0.0005
595 CONVULSION 26 0.0005
596 INJECTION SITE NODULE 5 0.0005
597 HYPERSOMNIA 13 0.0005
598 LOSS OF CONSCIOUSNESS 58 0.0005
599 PRESYNCOPE 11 0.0005
600 NEURALGIA 11 0.0005
601 MUSCULOSKELETAL CHEST PAIN 7 0.0005
602 SPINAL FRACTURE 9 0.0004
603 NERVOUS SYSTEM DISORDER 14 0.0004
604 MENINGIOMA 7 0.0004
605 MALNUTRITION 5 0.0004
606 FEAR 12 0.0004
607 NEPHROPATHY TOXIC 5 0.0004
608 INTENTIONAL PRODUCT USE ISSUE 39 0.0004
609 MUSCULOSKELETAL STIFFNESS 39 0.0004
610 BLOOD CALCIUM DECREASED 5 0.0004
611 PRODUCT TASTE ABNORMAL 6 0.0004
612 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
613 HEAD INJURY 14 0.0004
614 ATRIAL FIBRILLATION 43 0.0004
615 RESPIRATORY TRACT CONGESTION 7 0.0004
616 CRYING 16 0.0004
617 RESTLESSNESS 16 0.0004
618 CARDIAC FAILURE 35 0.0004
619 ANXIETY 124 0.0004
620 FLUID RETENTION 22 0.0004
621 MEDICATION ERROR 24 0.0004
622 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
623 THINKING ABNORMAL 8 0.0004
624 VENTRICULAR TACHYCARDIA 7 0.0004
625 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
626 HYPOCALCAEMIA 8 0.0004
627 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
628 SPEECH DISORDER 22 0.0004
629 SUBDURAL HAEMATOMA 6 0.0004
630 MACULAR DEGENERATION 5 0.0004
631 WRIST FRACTURE 5 0.0004
632 ANGER 14 0.0004
633 HEART RATE INCREASED 41 0.0004
634 LOCALISED INFECTION 10 0.0004
635 PRESCRIBED OVERDOSE 8 0.0004
636 DYSSTASIA 12 0.0004
637 HAEMATURIA 14 0.0004
638 DEPRESSION 93 0.0004
639 KIDNEY INFECTION 8 0.0004
640 RHABDOMYOLYSIS 17 0.0004
641 INFECTION 59 0.0004
642 DYSURIA 15 0.0004
643 FEBRILE NEUTROPENIA 27 0.0004
644 LIVER DISORDER 18 0.0004
645 TACHYCARDIA 36 0.0004
646 LIMB INJURY 11 0.0004
647 MUSCULAR WEAKNESS 46 0.0004
648 BACK PAIN 94 0.0004
649 GENERALISED OEDEMA 5 0.0004
650 IMMUNODEFICIENCY 6 0.0004
651 RHINORRHOEA 26 0.0004
652 PANCREATITIS ACUTE 9 0.0004
653 CORONARY ARTERY DISEASE 12 0.0004
654 FEELING COLD 11 0.0004
655 DEMENTIA 11 0.0004
656 THIRST 7 0.0004
657 GASTROINTESTINAL DISORDER 35 0.0004
658 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
659 RIB FRACTURE 8 0.0004
660 ILLNESS 40 0.0004
661 GASTROENTERITIS VIRAL 7 0.0004
662 ANKLE FRACTURE 6 0.0004
663 ABDOMINAL DISCOMFORT 65 0.0004
664 EJECTION FRACTION DECREASED 6 0.0004
665 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
666 PRODUCT USE COMPLAINT 6 0.0004
667 HYPOAESTHESIA 57 0.0004
668 IMMUNE SYSTEM DISORDER 5 0.0004
669 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
670 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
671 SURGERY 22 0.0004
672 BACTERIAL INFECTION 7 0.0004
673 MIDDLE INSOMNIA 7 0.0004
674 DECREASED APPETITE 87 0.0004
675 BODY HEIGHT DECREASED 4 0.0004
676 IRRITABLE BOWEL SYNDROME 8 0.0004
677 VOMITING 175 0.0004
678 HALLUCINATION 28 0.0004
679 MATERNAL EXPOSURE DURING PREGNANCY 33 0.0004
680 FIBROMYALGIA 9 0.0004
681 FRACTURE 7 0.0004
682 FALL 123 0.0004
683 NEUROPATHY PERIPHERAL 35 0.0004
684 BLOOD CREATININE INCREASED 24 0.0004
685 DRUG TOXICITY 5 0.0004
686 MOOD ALTERED 10 0.0004
687 WEIGHT DECREASED 102 0.0004
688 HEPATIC FAILURE 11 0.0004
689 STAPHYLOCOCCAL INFECTION 12 0.0004
690 CHEST PAIN 67 0.0004
691 EPISTAXIS 27 0.0004
692 GAIT DISTURBANCE 69 0.0004
693 FUNGAL INFECTION 12 0.0004
694 HYPOMAGNESAEMIA 5 0.0004
695 HAEMORRHOIDS 7 0.0004
696 HYPERTENSION 76 0.0004
697 ORAL HERPES 7 0.0004
698 PANCYTOPENIA 20 0.0004
699 MASS 5 0.0004
700 DRY MOUTH 29 0.0004
701 SNEEZING 8 0.0004
702 HEMIPARESIS 6 0.0004
703 BLOOD PRESSURE INCREASED 54 0.0004
704 PYREXIA 122 0.0004
705 SINUS TACHYCARDIA 5 0.0004
706 PAIN IN EXTREMITY 103 0.0003
707 EYE SWELLING 13 0.0003
708 ANAPHYLACTIC SHOCK 9 0.0003
709 WEIGHT INCREASED 78 0.0003
710 GASTROOESOPHAGEAL REFLUX DISEASE 28 0.0003
711 COVID-19 61 0.0003
712 PRODUCT PHYSICAL ISSUE 7 0.0003
713 PARAESTHESIA ORAL 5 0.0003
714 MYELODYSPLASTIC SYNDROME 5 0.0003
715 FEEDING DISORDER 7 0.0003
716 VERTIGO 21 0.0003
717 BODY TEMPERATURE INCREASED 7 0.0003
718 AGITATION 25 0.0003
719 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
720 PERITONITIS 7 0.0003
721 FATIGUE 263 0.0003
722 PRODUCT PRESCRIBING ERROR 8 0.0003
723 ABDOMINAL PAIN UPPER 69 0.0003
724 OROPHARYNGEAL PAIN 31 0.0003
725 DISTURBANCE IN ATTENTION 18 0.0003
726 PREMATURE BABY 10 0.0003
727 APHASIA 10 0.0003
728 BLOOD PRESSURE DECREASED 22 0.0003
729 THROMBOCYTOPENIA 37 0.0003
730 ANAEMIA 63 0.0003
731 OSTEOARTHRITIS 14 0.0003
732 PRODUCT USE ISSUE 62 0.0003
733 STOMATITIS 20 0.0003
734 PANIC ATTACK 12 0.0003
735 DIZZINESS 164 0.0003
736 NAUSEA 259 0.0003
737 CYTOPENIA 4 0.0003
738 DYSPHAGIA 31 0.0003
739 RESPIRATORY ARREST 9 0.0003
740 NERVOUSNESS 17 0.0003
741 DEVICE RELATED INFECTION 5 0.0003
742 ABORTION SPONTANEOUS 13 0.0003
743 HAEMOGLOBIN DECREASED 33 0.0003
744 ARRHYTHMIA 15 0.0003
745 ASTHENIA 119 0.0003
746 PALPITATIONS 37 0.0003
747 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
748 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
749 HALLUCINATION, AUDITORY 5 0.0003
750 ANGINA PECTORIS 9 0.0003
751 PREMATURE DELIVERY 5 0.0003
752 SEPSIS 35 0.0003
753 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
754 GLOSSODYNIA 7 0.0003
755 POLLAKIURIA 13 0.0003
756 HERNIA 6 0.0003
757 SKIN ULCER 8 0.0003
758 CEREBRAL HAEMORRHAGE 11 0.0003
759 CONSTIPATION 67 0.0003
760 ANHEDONIA 8 0.0003
761 MULTIPLE FRACTURES 5 0.0003
762 URINARY INCONTINENCE 9 0.0003
763 ARTHRALGIA 126 0.0003
764 PHOTOSENSITIVITY REACTION 5 0.0003
765 C-REACTIVE PROTEIN INCREASED 11 0.0003
766 HYPOACUSIS 13 0.0003
767 BLOOD PRESSURE ABNORMAL 6 0.0003
768 DIABETES MELLITUS 23 0.0003
769 COMPLICATION OF DEVICE INSERTION 6 0.0003
770 CONTUSION 29 0.0003
771 UPPER LIMB FRACTURE 6 0.0003
772 LIP SWELLING 10 0.0003
773 PNEUMONIA 97 0.0003
774 GAIT INABILITY 10 0.0003
775 MENTAL DISORDER 13 0.0003
776 COUGH 83 0.0003
777 SUICIDAL IDEATION 27 0.0003
778 ACNE 22 0.0003
779 PARANOIA 5 0.0003
780 SYNCOPE 29 0.0003
781 MULTI-ORGAN FAILURE 5 0.0003
782 DIVERTICULITIS 8 0.0003
783 SWOLLEN TONGUE 9 0.0003
784 COMPLETED SUICIDE 24 0.0003
785 COORDINATION ABNORMAL 4 0.0003
786 INFUSION RELATED REACTION 19 0.0003
787 DERMATITIS 6 0.0003
788 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
789 EOSINOPHILIA 5 0.0003
790 DIARRHOEA 184 0.0003
791 MEMORY IMPAIRMENT 39 0.0003
792 DEPRESSED MOOD 15 0.0003
793 BRONCHITIS 21 0.0003
794 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
795 OSTEONECROSIS OF JAW 7 0.0003
796 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
797 IMPAIRED WORK ABILITY 6 0.0003
798 FEELING ABNORMAL 67 0.0003
799 HEPATIC ENZYME INCREASED 19 0.0003
800 GOUT 5 0.0003
801 EYE IRRITATION 16 0.0003
802 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
803 CELLULITIS 14 0.0003
804 COMPLICATION OF DEVICE REMOVAL 5 0.0003
805 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
806 DRUG EFFECT INCOMPLETE 10 0.0003
807 PELVIC PAIN 5 0.0003
808 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
809 JOINT SWELLING 33 0.0003
810 ASCITES 8 0.0003
811 ABDOMINAL PAIN 63 0.0003
812 BLOOD GLUCOSE ABNORMAL 5 0.0003
813 VIRAL INFECTION 9 0.0003
814 INJURY 19 0.0003
815 HAEMATOMA 7 0.0003
816 DEAFNESS 7 0.0003
817 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
818 SWELLING 25 0.0003
819 BLISTER 15 0.0003
820 PAIN 164 0.0003
821 HEPATIC CIRRHOSIS 5 0.0003
822 RASH 115 0.0003
823 CHEST DISCOMFORT 27 0.0003
824 BLOOD URINE PRESENT 5 0.0003
825 HERPES ZOSTER 15 0.0003
826 LOWER LIMB FRACTURE 5 0.0003
827 INSOMNIA 69 0.0003
828 PRODUCT DOSE OMISSION ISSUE 76 0.0003
829 RASH MACULAR 9 0.0003
830 HEART RATE DECREASED 9 0.0003
831 RECTAL HAEMORRHAGE 11 0.0003
832 RHEUMATOID ARTHRITIS 29 0.0003
833 OEDEMA PERIPHERAL 31 0.0003
834 LYMPHADENOPATHY 9 0.0003
835 ANAPHYLACTIC REACTION 14 0.0003
836 THERAPY CESSATION 13 0.0003
837 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
838 SINUS DISORDER 5 0.0003
839 ABNORMAL BEHAVIOUR 10 0.0003
840 INFLUENZA 28 0.0003
841 MULTIPLE SCLEROSIS 12 0.0003
842 ABSCESS 4 0.0003
843 SKIN EXFOLIATION 21 0.0002
844 HYPOGLYCAEMIA 12 0.0002
845 PRODUCT ADMINISTRATION ERROR 5 0.0002
846 HOSPITALISATION 38 0.0002
847 DEVICE BREAKAGE 10 0.0002
848 DEEP VEIN THROMBOSIS 16 0.0002
849 SWELLING FACE 16 0.0002
850 INTENTIONAL DOSE OMISSION 7 0.0002
851 LIVER INJURY 6 0.0002
852 NASOPHARYNGITIS 45 0.0002
853 OSTEONECROSIS 8 0.0002
854 INJECTION SITE MASS 9 0.0002
855 OSTEOPOROSIS 10 0.0002
856 ABASIA 6 0.0002
857 NEUTROPENIA 33 0.0002
858 BURNING SENSATION 17 0.0002
859 CYTOMEGALOVIRUS INFECTION 4 0.0002
860 AGEUSIA 6 0.0002
861 SKIN DISORDER 8 0.0002
862 ABDOMINAL DISTENSION 25 0.0002
863 SKIN DISCOLOURATION 11 0.0002
864 INTESTINAL OBSTRUCTION 9 0.0002
865 UNEVALUABLE EVENT 18 0.0002
866 LABORATORY TEST ABNORMAL 7 0.0002
867 HYPERSENSITIVITY 44 0.0002
868 CEREBROVASCULAR ACCIDENT 40 0.0002
869 PLATELET COUNT DECREASED 25 0.0002
870 RETCHING 5 0.0002
871 RESPIRATORY DISORDER 7 0.0002
872 ADVERSE DRUG REACTION 21 0.0002
873 GASTRIC DISORDER 8 0.0002
874 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
875 UNDERDOSE 17 0.0002
876 POOR QUALITY SLEEP 5 0.0002
877 INFLUENZA LIKE ILLNESS 19 0.0002
878 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
879 ARTHRITIS 18 0.0002
880 DYSGEUSIA 17 0.0002
881 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
882 JAUNDICE 6 0.0002
883 TREMOR 37 0.0002
884 THROAT TIGHTNESS 6 0.0002
885 PNEUMONITIS 6 0.0002
886 PRODUCT AVAILABILITY ISSUE 5 0.0002
887 BONE DISORDER 4 0.0002
888 HAEMATOCHEZIA 12 0.0002
889 ABNORMAL DREAMS 6 0.0002
890 INTENTIONAL PRODUCT MISUSE 19 0.0002
891 ARTHROPATHY 12 0.0002
892 ROAD TRAFFIC ACCIDENT 9 0.0002
893 WITHDRAWAL SYNDROME 9 0.0002
894 MUSCLE SPASMS 39 0.0002
895 PAIN IN JAW 6 0.0002
896 HAEMORRHAGE 22 0.0002
897 URINARY RETENTION 7 0.0002
898 HYPERHIDROSIS 27 0.0002
899 RASH ERYTHEMATOUS 10 0.0002
900 PRODUCT SUBSTITUTION ISSUE 12 0.0002
901 MALAISE 90 0.0002
902 DYSPHONIA 12 0.0002
903 CHOKING 4 0.0002
904 BONE PAIN 12 0.0002
905 ERYTHEMA 42 0.0002
906 URTICARIA 34 0.0002
907 NEOPLASM PROGRESSION 7 0.0002
908 THROAT IRRITATION 9 0.0002
909 PRODUCT DOSE OMISSION 13 0.0002
910 ABDOMINAL PAIN LOWER 5 0.0002
911 NEUTROPHIL COUNT DECREASED 8 0.0002
912 THERAPY INTERRUPTED 14 0.0002
913 FEELING HOT 12 0.0002
914 HEPATITIS 5 0.0002
915 MOBILITY DECREASED 14 0.0002
916 EMOTIONAL DISORDER 6 0.0002
917 FEMUR FRACTURE 6 0.0002
918 DYSPEPSIA 19 0.0002
919 EXPOSURE VIA SKIN CONTACT 5 0.0002
920 CARDIAC DISORDER 18 0.0002
921 MUCOSAL INFLAMMATION 5 0.0002
922 JOINT STIFFNESS 5 0.0002
923 OVERDOSE 41 0.0002
924 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
925 ALOPECIA 37 0.0002
926 MOOD SWINGS 6 0.0002
927 CHILLS 22 0.0002
928 BLOOD GLUCOSE DECREASED 9 0.0002
929 MOVEMENT DISORDER 6 0.0002
930 FREQUENT BOWEL MOVEMENTS 5 0.0002
931 COLITIS 7 0.0002
932 ADVERSE EVENT 17 0.0002
933 IMPAIRED HEALING 6 0.0002
934 NO ADVERSE EVENT 33 0.0002
935 PERIPHERAL SWELLING 28 0.0002
936 ILL-DEFINED DISORDER 11 0.0002
937 PROCEDURAL PAIN 5 0.0002
938 WOUND 5 0.0002
939 RED BLOOD CELL COUNT DECREASED 5 0.0002
940 RENAL DISORDER 8 0.0002
941 BLOOD GLUCOSE INCREASED 31 0.0002
942 INJECTION SITE RASH 5 0.0002
943 HOT FLUSH 12 0.0002
944 CARDIOVASCULAR DISORDER 4 0.0002
945 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
946 DEVICE ISSUE 14 0.0002
947 MUSCULOSKELETAL PAIN 8 0.0002
948 CHOLELITHIASIS 5 0.0002
949 EXPIRED PRODUCT ADMINISTERED 5 0.0002
950 MYOCARDIAL INFARCTION 26 0.0001
951 EYE PRURITUS 5 0.0001
952 SUICIDE ATTEMPT 9 0.0001
953 PRURITUS 57 0.0001
954 EXTRA DOSE ADMINISTERED 6 0.0001
955 BLOOD BILIRUBIN INCREASED 4 0.0001
956 FLUSHING 15 0.0001
957 MYALGIA 25 0.0001
958 INTERSTITIAL LUNG DISEASE 7 0.0001
959 NIGHTMARE 5 0.0001
960 FLATULENCE 8 0.0001
961 MYELOSUPPRESSION 5 0.0001
962 DEATH 119 0.0001
963 DEVICE DISLOCATION 6 0.0001
964 INJECTION SITE HAEMORRHAGE 11 0.0001
965 DRY SKIN 17 0.0001
966 INJECTION SITE BRUISING 10 0.0001
967 INTENTIONAL OVERDOSE 8 0.0001
968 EMOTIONAL DISTRESS 15 0.0001
969 LUNG NEOPLASM MALIGNANT 5 0.0001
970 INJECTION SITE SWELLING 9 0.0001
971 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
972 VAGINAL HAEMORRHAGE 5 0.0001
973 ECZEMA 6 0.0001
974 INJECTION SITE ERYTHEMA 14 0.0001
975 ACCIDENTAL OVERDOSE 4 0.0001
976 INJECTION SITE PRURITUS 7 0.0001
977 PRODUCT QUALITY ISSUE 14 0.0001
978 INJECTION SITE REACTION 7 0.0001
979 INCORRECT DOSE ADMINISTERED 23 0.0001
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
981 DISCOMFORT 6 0.0001
982 DRUG DOSE OMISSION 16 0.0001
983 INJECTION SITE PAIN 29 0.0001
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
985 BLOOD CHOLESTEROL INCREASED 4 0.0001
986 PSORIASIS 11 0.0001
987 PRODUCT STORAGE ERROR 7 0.0001
988 BREAST CANCER 7 0.0001
989 SKIN BURNING SENSATION 5 0.0001
990 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001